TrianglePUBLICATIONS · 24827123
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2014 Aug
- First author
- Mounier N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mounier N
- type
- Author
- name
- Brice P
- type
- Author
- name
- Bologna S
- type
- Author
- name
- Briere J
- type
- Author
- name
- Gaillard I
- type
- Author
- name
- Heczko M
- type
- Author
- name
- Gabarre J
- type
- Author
- name
- Casasnovas O
- type
- Author
- name
- Jaubert J
- type
- Author
- name
- Colin P
- type
- Author
- name
- Delmer A
- type
- Author
- name
- Devidas A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mounier N
- type
- Author
- name
- Brice P
- type
- Author
- name
- Bologna S
- type
- Author
- name
- Briere J
- type
- Author
- name
- Gaillard I
- type
- Author
- name
- Heczko M
- type
- Author
- name
- Gabarre J
- type
- Author
- name
- Casasnovas O
- type
- Author
- name
- Jaubert J
- type
- Author
- name
- Colin P
- type
- Author
- name
- Delmer A
- type
- Author
- name
- Devidas A
- type
- Author
- bibliography ids
- nci-bib-da6ba94bbc0b465a7e6d51a7
- book metadata
- content sha256
- 426b83d991105116f3c225b73c3d5332fec0b5aa2e433369cebe9a5df02b4262
- document type
- citation
- dois
- 10.1093/annonc/mdu189
- electronic publication date
- display
- 2014 May 14
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24827123
- immutable id
- pubmed:24827123@426b83d991105116f3c225b73c3d5332fec0b5aa2e433369cebe9a5df02b4262
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 8
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1622-8
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24827123
- provenance
- batch id
- 063b6c38419f18d4021f
- provider
- NCBI PubMed ESummary
- record sha256
- c4dafa6f1df2ddd7e6aef0fe1b75e0b1aef56d223666961723a018d7a48b2222
- response sha256
- 5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
- retrieved at
- 2026-09-09T23:47:02.607425+00:00
- publication date
- display
- 2014 Aug
- precision
- month
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
Preserved source evidence · Not medical advice